• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

COVID-19 Impact on Global Varicella Live Vaccine Market Insights, Forecast to 2026

report cover
  • 22 June 2020
  • Healthcare
  • 145 Pages
  • Report Code: 24LS-8546
  • Formate :   
Download FREE Report Sample Download PDF File

COVID 19 Impact Varicella Live Vaccine -MARKET ADVISORY SERVICES

Varicella Live Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Varicella Live Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Varicella Live Vaccine market is segmented into
Monovalent Vaccines
Multivalent Vaccines

Segment by Application, the Varicella Live Vaccine market is segmented into
Chicken Pox Immunization
Herpes Zoster Immunization
Measles Immunization
Others

Regional and Country-level Analysis
The Varicella Live Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Varicella Live Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Varicella Live Vaccine Market Share Analysis
Varicella Live Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Varicella Live Vaccine business, the date to enter into the Varicella Live Vaccine market, Varicella Live Vaccine product introduction, recent developments, etc.
The major vendors covered:
Astellas Pharma Inc.
CSL Limited
Emergent BioSolutions, Inc.
GlaxoSmithKline plc
Johnson & Johnson
MedImmune, LLC
Merck & Co., Inc.
Pfizer, Inc.
Sanofi Pasteur
Serum Institute of India Pvt. Ltd.
Bavarian Nordic
Mitsubishi Tanabe Pharma Corporation
Daiichi Sankyo
Biological E
Panacea Biotec
1 Study Coverage
1.1 Varicella Live Vaccine Product Introduction
1.2 Market Segments
1.3 Key Varicella Live Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Varicella Live Vaccine Market Size Growth Rate by Type
1.4.2 Monovalent Vaccines
1.4.3 Multivalent Vaccines
1.5 Market by Application
1.5.1 Global Varicella Live Vaccine Market Size Growth Rate by Application
1.5.2 Chicken Pox Immunization
1.5.3 Herpes Zoster Immunization
1.5.4 Measles Immunization
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Varicella Live Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the Varicella Live Vaccine Industry
1.6.1.1 Varicella Live Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Varicella Live Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Varicella Live Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Varicella Live Vaccine Market Size Estimates and Forecasts
2.1.1 Global Varicella Live Vaccine Revenue 2015-2026
2.1.2 Global Varicella Live Vaccine Sales 2015-2026
2.2 Varicella Live Vaccine Market Size by Region: 2020 Versus 2026
2.2.1 Global Varicella Live Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Varicella Live Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Varicella Live Vaccine Competitor Landscape by Players
3.1 Varicella Live Vaccine Sales by Manufacturers
3.1.1 Varicella Live Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Varicella Live Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Varicella Live Vaccine Revenue by Manufacturers
3.2.1 Varicella Live Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Varicella Live Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Varicella Live Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Varicella Live Vaccine Revenue in 2019
3.2.5 Global Varicella Live Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Varicella Live Vaccine Price by Manufacturers
3.4 Varicella Live Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Varicella Live Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Varicella Live Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Varicella Live Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Varicella Live Vaccine Market Size by Type (2015-2020)
4.1.1 Global Varicella Live Vaccine Sales by Type (2015-2020)
4.1.2 Global Varicella Live Vaccine Revenue by Type (2015-2020)
4.1.3 Varicella Live Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Varicella Live Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Varicella Live Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Varicella Live Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Varicella Live Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Varicella Live Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)
5.1 Global Varicella Live Vaccine Market Size by Application (2015-2020)
5.1.1 Global Varicella Live Vaccine Sales by Application (2015-2020)
5.1.2 Global Varicella Live Vaccine Revenue by Application (2015-2020)
5.1.3 Varicella Live Vaccine Price by Application (2015-2020)
5.2 Varicella Live Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Varicella Live Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Varicella Live Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Varicella Live Vaccine Price Forecast by Application (2021-2026)

6 North America
6.1 North America Varicella Live Vaccine by Country
6.1.1 North America Varicella Live Vaccine Sales by Country
6.1.2 North America Varicella Live Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Varicella Live Vaccine Market Facts & Figures by Type
6.3 North America Varicella Live Vaccine Market Facts & Figures by Application

7 Europe
7.1 Europe Varicella Live Vaccine by Country
7.1.1 Europe Varicella Live Vaccine Sales by Country
7.1.2 Europe Varicella Live Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Varicella Live Vaccine Market Facts & Figures by Type
7.3 Europe Varicella Live Vaccine Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Varicella Live Vaccine by Region
8.1.1 Asia Pacific Varicella Live Vaccine Sales by Region
8.1.2 Asia Pacific Varicella Live Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Varicella Live Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Varicella Live Vaccine Market Facts & Figures by Application

9 Latin America
9.1 Latin America Varicella Live Vaccine by Country
9.1.1 Latin America Varicella Live Vaccine Sales by Country
9.1.2 Latin America Varicella Live Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Varicella Live Vaccine Market Facts & Figures by Type
9.3 Central & South America Varicella Live Vaccine Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Varicella Live Vaccine by Country
10.1.1 Middle East and Africa Varicella Live Vaccine Sales by Country
10.1.2 Middle East and Africa Varicella Live Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Varicella Live Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Varicella Live Vaccine Market Facts & Figures by Application

11 Company Profiles
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Corporation Information
11.1.2 Astellas Pharma Inc. Description, Business Overview and Total Revenue
11.1.3 Astellas Pharma Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Astellas Pharma Inc. Varicella Live Vaccine Products Offered
11.1.5 Astellas Pharma Inc. Recent Development
11.2 CSL Limited
11.2.1 CSL Limited Corporation Information
11.2.2 CSL Limited Description, Business Overview and Total Revenue
11.2.3 CSL Limited Sales, Revenue and Gross Margin (2015-2020)
11.2.4 CSL Limited Varicella Live Vaccine Products Offered
11.2.5 CSL Limited Recent Development
11.3 Emergent BioSolutions, Inc.
11.3.1 Emergent BioSolutions, Inc. Corporation Information
11.3.2 Emergent BioSolutions, Inc. Description, Business Overview and Total Revenue
11.3.3 Emergent BioSolutions, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Emergent BioSolutions, Inc. Varicella Live Vaccine Products Offered
11.3.5 Emergent BioSolutions, Inc. Recent Development
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Corporation Information
11.4.2 GlaxoSmithKline plc Description, Business Overview and Total Revenue
11.4.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline plc Varicella Live Vaccine Products Offered
11.4.5 GlaxoSmithKline plc Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Description, Business Overview and Total Revenue
11.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Johnson & Johnson Varicella Live Vaccine Products Offered
11.5.5 Johnson & Johnson Recent Development
11.6 MedImmune, LLC
11.6.1 MedImmune, LLC Corporation Information
11.6.2 MedImmune, LLC Description, Business Overview and Total Revenue
11.6.3 MedImmune, LLC Sales, Revenue and Gross Margin (2015-2020)
11.6.4 MedImmune, LLC Varicella Live Vaccine Products Offered
11.6.5 MedImmune, LLC Recent Development
11.7 Merck & Co., Inc.
11.7.1 Merck & Co., Inc. Corporation Information
11.7.2 Merck & Co., Inc. Description, Business Overview and Total Revenue
11.7.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merck & Co., Inc. Varicella Live Vaccine Products Offered
11.7.5 Merck & Co., Inc. Recent Development
11.8 Pfizer, Inc.
11.8.1 Pfizer, Inc. Corporation Information
11.8.2 Pfizer, Inc. Description, Business Overview and Total Revenue
11.8.3 Pfizer, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Pfizer, Inc. Varicella Live Vaccine Products Offered
11.8.5 Pfizer, Inc. Recent Development
11.9 Sanofi Pasteur
11.9.1 Sanofi Pasteur Corporation Information
11.9.2 Sanofi Pasteur Description, Business Overview and Total Revenue
11.9.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Sanofi Pasteur Varicella Live Vaccine Products Offered
11.9.5 Sanofi Pasteur Recent Development
11.10 Serum Institute of India Pvt. Ltd.
11.10.1 Serum Institute of India Pvt. Ltd. Corporation Information
11.10.2 Serum Institute of India Pvt. Ltd. Description, Business Overview and Total Revenue
11.10.3 Serum Institute of India Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Serum Institute of India Pvt. Ltd. Varicella Live Vaccine Products Offered
11.10.5 Serum Institute of India Pvt. Ltd. Recent Development
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Corporation Information
11.1.2 Astellas Pharma Inc. Description, Business Overview and Total Revenue
11.1.3 Astellas Pharma Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Astellas Pharma Inc. Varicella Live Vaccine Products Offered
11.1.5 Astellas Pharma Inc. Recent Development
11.12 Mitsubishi Tanabe Pharma Corporation
11.12.1 Mitsubishi Tanabe Pharma Corporation Corporation Information
11.12.2 Mitsubishi Tanabe Pharma Corporation Description, Business Overview and Total Revenue
11.12.3 Mitsubishi Tanabe Pharma Corporation Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Mitsubishi Tanabe Pharma Corporation Products Offered
11.12.5 Mitsubishi Tanabe Pharma Corporation Recent Development
11.13 Daiichi Sankyo
11.13.1 Daiichi Sankyo Corporation Information
11.13.2 Daiichi Sankyo Description, Business Overview and Total Revenue
11.13.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Daiichi Sankyo Products Offered
11.13.5 Daiichi Sankyo Recent Development
11.14 Biological E
11.14.1 Biological E Corporation Information
11.14.2 Biological E Description, Business Overview and Total Revenue
11.14.3 Biological E Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Biological E Products Offered
11.14.5 Biological E Recent Development
11.15 Panacea Biotec
11.15.1 Panacea Biotec Corporation Information
11.15.2 Panacea Biotec Description, Business Overview and Total Revenue
11.15.3 Panacea Biotec Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Panacea Biotec Products Offered
11.15.5 Panacea Biotec Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Varicella Live Vaccine Market Estimates and Projections by Region
12.1.1 Global Varicella Live Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Varicella Live Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Varicella Live Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Varicella Live Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Varicella Live Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Varicella Live Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Varicella Live Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Varicella Live Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Varicella Live Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Varicella Live Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Varicella Live Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Varicella Live Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Varicella Live Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Varicella Live Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Varicella Live Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Varicella Live Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Varicella Live Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Varicella Live Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Varicella Live Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Varicella Live Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Varicella Live Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Varicella Live Vaccine Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Varicella Live Vaccine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Varicella Live Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables

Table 1. Varicella Live Vaccine Market Segments

Table 2. Ranking of Global Top Varicella Live Vaccine Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Varicella Live Vaccine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)

Table 4. Major Manufacturers of Monovalent Vaccines

Table 5. Major Manufacturers of Multivalent Vaccines

Table 6. COVID-19 Impact Global Market: (Four Varicella Live Vaccine Market Size Forecast Scenarios)

Table 7. Opportunities and Trends for Varicella Live Vaccine Players in the COVID-19 Landscape

Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 9. Key Regions/Countries Measures against Covid-19 Impact

Table 10. Proposal for Varicella Live Vaccine Players to Combat Covid-19 Impact

Table 11. Global Varicella Live Vaccine Market Size Growth Rate by Application 2020-2026 (K Units)

Table 12. Global Varicella Live Vaccine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026

Table 13. Global Varicella Live Vaccine Sales by Regions 2015-2020 (K Units)

Table 14. Global Varicella Live Vaccine Sales Market Share by Regions (2015-2020)

Table 15. Global Varicella Live Vaccine Revenue by Regions 2015-2020 (US$ Million)

Table 16. Global Varicella Live Vaccine Sales by Manufacturers (2015-2020) (K Units)

Table 17. Global Varicella Live Vaccine Sales Share by Manufacturers (2015-2020)

Table 18. Global Varicella Live Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 19. Global Varicella Live Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Varicella Live Vaccine as of 2019)

Table 20. Varicella Live Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)

Table 21. Varicella Live Vaccine Revenue Share by Manufacturers (2015-2020)

Table 22. Key Manufacturers Varicella Live Vaccine Price (2015-2020) (USD/Unit)

Table 23. Varicella Live Vaccine Manufacturers Manufacturing Base Distribution and Headquarters

Table 24. Manufacturers Varicella Live Vaccine Product Type

Table 25. Date of International Manufacturers Enter into Varicella Live Vaccine Market

Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 27. Global Varicella Live Vaccine Sales by Type (2015-2020) (K Units)

Table 28. Global Varicella Live Vaccine Sales Share by Type (2015-2020)

Table 29. Global Varicella Live Vaccine Revenue by Type (2015-2020) (US$ Million)

Table 30. Global Varicella Live Vaccine Revenue Share by Type (2015-2020)

Table 31. Varicella Live Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)

Table 32. Global Varicella Live Vaccine Sales by Application (2015-2020) (K Units)

Table 33. Global Varicella Live Vaccine Sales Share by Application (2015-2020)

Table 34. North America Varicella Live Vaccine Sales by Country (2015-2020) (K Units)

Table 35. North America Varicella Live Vaccine Sales Market Share by Country (2015-2020)

Table 36. North America Varicella Live Vaccine Revenue by Country (2015-2020) (US$ Million)

Table 37. North America Varicella Live Vaccine Revenue Market Share by Country (2015-2020)

Table 38. North America Varicella Live Vaccine Sales by Type (2015-2020) (K Units)

Table 39. North America Varicella Live Vaccine Sales Market Share by Type (2015-2020)

Table 40. North America Varicella Live Vaccine Sales by Application (2015-2020) (K Units)

Table 41. North America Varicella Live Vaccine Sales Market Share by Application (2015-2020)

Table 42. Europe Varicella Live Vaccine Sales by Country (2015-2020) (K Units)

Table 43. Europe Varicella Live Vaccine Sales Market Share by Country (2015-2020)

Table 44. Europe Varicella Live Vaccine Revenue by Country (2015-2020) (US$ Million)

Table 45. Europe Varicella Live Vaccine Revenue Market Share by Country (2015-2020)

Table 46. Europe Varicella Live Vaccine Sales by Type (2015-2020) (K Units)

Table 47. Europe Varicella Live Vaccine Sales Market Share by Type (2015-2020)

Table 48. Europe Varicella Live Vaccine Sales by Application (2015-2020) (K Units)

Table 49. Europe Varicella Live Vaccine Sales Market Share by Application (2015-2020)

Table 50. Asia Pacific Varicella Live Vaccine Sales by Region (2015-2020) (K Units)

Table 51. Asia Pacific Varicella Live Vaccine Sales Market Share by Region (2015-2020)

Table 52. Asia Pacific Varicella Live Vaccine Revenue by Region (2015-2020) (US$ Million)

Table 53. Asia Pacific Varicella Live Vaccine Revenue Market Share by Region (2015-2020)

Table 54. Asia Pacific Varicella Live Vaccine Sales by Type (2015-2020) (K Units)

Table 55. Asia Pacific Varicella Live Vaccine Sales Market Share by Type (2015-2020)

Table 56. Asia Pacific Varicella Live Vaccine Sales by Application (2015-2020) (K Units)

Table 57. Asia Pacific Varicella Live Vaccine Sales Market Share by Application (2015-2020)

Table 58. Latin America Varicella Live Vaccine Sales by Country (2015-2020) (K Units)

Table 59. Latin America Varicella Live Vaccine Sales Market Share by Country (2015-2020)

Table 60. Latin Americaa Varicella Live Vaccine Revenue by Country (2015-2020) (US$ Million)

Table 61. Latin America Varicella Live Vaccine Revenue Market Share by Country (2015-2020)

Table 62. Latin America Varicella Live Vaccine Sales by Type (2015-2020) (K Units)

Table 63. Latin America Varicella Live Vaccine Sales Market Share by Type (2015-2020)

Table 64. Latin America Varicella Live Vaccine Sales by Application (2015-2020) (K Units)

Table 65. Latin America Varicella Live Vaccine Sales Market Share by Application (2015-2020)

Table 66. Middle East and Africa Varicella Live Vaccine Sales by Country (2015-2020) (K Units)

Table 67. Middle East and Africa Varicella Live Vaccine Sales Market Share by Country (2015-2020)

Table 68. Middle East and Africa Varicella Live Vaccine Revenue by Country (2015-2020) (US$ Million)

Table 69. Middle East and Africa Varicella Live Vaccine Revenue Market Share by Country (2015-2020)

Table 70. Middle East and Africa Varicella Live Vaccine Sales by Type (2015-2020) (K Units)

Table 71. Middle East and Africa Varicella Live Vaccine Sales Market Share by Type (2015-2020)

Table 72. Middle East and Africa Varicella Live Vaccine Sales by Application (2015-2020) (K Units)

Table 73. Middle East and Africa Varicella Live Vaccine Sales Market Share by Application (2015-2020)

Table 74. Astellas Pharma Inc. Corporation Information

Table 75. Astellas Pharma Inc. Description and Major Businesses

Table 76. Astellas Pharma Inc. Varicella Live Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 77. Astellas Pharma Inc. Product

Table 78. Astellas Pharma Inc. Recent Development

Table 79. CSL Limited Corporation Information

Table 80. CSL Limited Description and Major Businesses

Table 81. CSL Limited Varicella Live Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 82. CSL Limited Product

Table 83. CSL Limited Recent Development

Table 84. Emergent BioSolutions, Inc. Corporation Information

Table 85. Emergent BioSolutions, Inc. Description and Major Businesses

Table 86. Emergent BioSolutions, Inc. Varicella Live Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 87. Emergent BioSolutions, Inc. Product

Table 88. Emergent BioSolutions, Inc. Recent Development

Table 89. GlaxoSmithKline plc Corporation Information

Table 90. GlaxoSmithKline plc Description and Major Businesses

Table 91. GlaxoSmithKline plc Varicella Live Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 92. GlaxoSmithKline plc Product

Table 93. GlaxoSmithKline plc Recent Development

Table 94. Johnson & Johnson Corporation Information

Table 95. Johnson & Johnson Description and Major Businesses

Table 96. Johnson & Johnson Varicella Live Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 97. Johnson & Johnson Product

Table 98. Johnson & Johnson Recent Development

Table 99. MedImmune, LLC Corporation Information

Table 100. MedImmune, LLC Description and Major Businesses

Table 101. MedImmune, LLC Varicella Live Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 102. MedImmune, LLC Product

Table 103. MedImmune, LLC Recent Development

Table 104. Merck & Co., Inc. Corporation Information

Table 105. Merck & Co., Inc. Description and Major Businesses

Table 106. Merck & Co., Inc. Varicella Live Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 107. Merck & Co., Inc. Product

Table 108. Merck & Co., Inc. Recent Development

Table 109. Pfizer, Inc. Corporation Information

Table 110. Pfizer, Inc. Description and Major Businesses

Table 111. Pfizer, Inc. Varicella Live Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 112. Pfizer, Inc. Product

Table 113. Pfizer, Inc. Recent Development

Table 114. Sanofi Pasteur Corporation Information

Table 115. Sanofi Pasteur Description and Major Businesses

Table 116. Sanofi Pasteur Varicella Live Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 117. Sanofi Pasteur Product

Table 118. Sanofi Pasteur Recent Development

Table 119. Serum Institute of India Pvt. Ltd. Corporation Information

Table 120. Serum Institute of India Pvt. Ltd. Description and Major Businesses

Table 121. Serum Institute of India Pvt. Ltd. Varicella Live Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 122. Serum Institute of India Pvt. Ltd. Product

Table 123. Serum Institute of India Pvt. Ltd. Recent Development

Table 124. Bavarian Nordic Corporation Information

Table 125. Bavarian Nordic Description and Major Businesses

Table 126. Bavarian Nordic Varicella Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 127. Bavarian Nordic Product

Table 128. Bavarian Nordic Recent Development

Table 129. Mitsubishi Tanabe Pharma Corporation Corporation Information

Table 130. Mitsubishi Tanabe Pharma Corporation Description and Major Businesses

Table 131. Mitsubishi Tanabe Pharma Corporation Varicella Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 132. Mitsubishi Tanabe Pharma Corporation Product

Table 133. Mitsubishi Tanabe Pharma Corporation Recent Development

Table 134. Daiichi Sankyo Corporation Information

Table 135. Daiichi Sankyo Description and Major Businesses

Table 136. Daiichi Sankyo Varicella Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 137. Daiichi Sankyo Product

Table 138. Daiichi Sankyo Recent Development

Table 139. Biological E Corporation Information

Table 140. Biological E Description and Major Businesses

Table 141. Biological E Varicella Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 142. Biological E Product

Table 143. Biological E Recent Development

Table 144. Panacea Biotec Corporation Information

Table 145. Panacea Biotec Description and Major Businesses

Table 146. Panacea Biotec Varicella Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 147. Panacea Biotec Product

Table 148. Panacea Biotec Recent Development

Table 149. Global Varicella Live Vaccine Sales Forecast by Regions (2021-2026) (K Units)

Table 150. Global Varicella Live Vaccine Sales Market Share Forecast by Regions (2021-2026)

Table 151. Global Varicella Live Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)

Table 152. Global Varicella Live Vaccine Revenue Market Share Forecast by Regions (2021-2026)

Table 153. North America: Varicella Live Vaccine Sales Forecast by Country (2021-2026) (K Units)

Table 154. North America: Varicella Live Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)

Table 155. Europe: Varicella Live Vaccine Sales Forecast by Country (2021-2026) (K Units)

Table 156. Europe: Varicella Live Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)

Table 157. Asia Pacific: Varicella Live Vaccine Sales Forecast by Region (2021-2026) (K Units)

Table 158. Asia Pacific: Varicella Live Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)

Table 159. Latin America: Varicella Live Vaccine Sales Forecast by Country (2021-2026) (K Units)

Table 160. Latin America: Varicella Live Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)

Table 161. Middle East and Africa: Varicella Live Vaccine Sales Forecast by Country (2021-2026) (K Units)

Table 162. Middle East and Africa: Varicella Live Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)

Table 163. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 164. Key Challenges

Table 165. Market Risks

Table 166. Main Points Interviewed from Key Varicella Live Vaccine Players

Table 167. Varicella Live Vaccine Customers List

Table 168. Varicella Live Vaccine Distributors List

Table 169. Research Programs/Design for This Report

Table 170. Key Data Information from Secondary Sources

Table 171. Key Data Information from Primary Sources

List of Figures

Figure 1. Varicella Live Vaccine Product Picture

Figure 2. Global Varicella Live Vaccine Sales Market Share by Type in 2020 & 2026

Figure 3. Monovalent Vaccines Product Picture

Figure 4. Multivalent Vaccines Product Picture

Figure 5. Global Varicella Live Vaccine Sales Market Share by Application in 2020 & 2026

Figure 6. Chicken Pox Immunization

Figure 7. Herpes Zoster Immunization

Figure 8. Measles Immunization

Figure 9. Others

Figure 10. Varicella Live Vaccine Report Years Considered

Figure 11. Global Varicella Live Vaccine Market Size 2015-2026 (US$ Million)

Figure 12. Global Varicella Live Vaccine Sales 2015-2026 (K Units)

Figure 13. Global Varicella Live Vaccine Market Size Market Share by Region: 2020 Versus 2026

Figure 14. Global Varicella Live Vaccine Sales Market Share by Region (2015-2020)

Figure 15. Global Varicella Live Vaccine Sales Market Share by Region in 2019

Figure 16. Global Varicella Live Vaccine Revenue Market Share by Region (2015-2020)

Figure 17. Global Varicella Live Vaccine Revenue Market Share by Region in 2019

Figure 18. Global Varicella Live Vaccine Sales Share by Manufacturer in 2019

Figure 19. The Top 10 and 5 Players Market Share by Varicella Live Vaccine Revenue in 2019

Figure 20. Varicella Live Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 21. Global Varicella Live Vaccine Sales Market Share by Type (2015-2020)

Figure 22. Global Varicella Live Vaccine Sales Market Share by Type in 2019

Figure 23. Global Varicella Live Vaccine Revenue Market Share by Type (2015-2020)

Figure 24. Global Varicella Live Vaccine Revenue Market Share by Type in 2019

Figure 25. Global Varicella Live Vaccine Market Share by Price Range (2015-2020)

Figure 26. Global Varicella Live Vaccine Sales Market Share by Application (2015-2020)

Figure 27. Global Varicella Live Vaccine Sales Market Share by Application in 2019

Figure 28. Global Varicella Live Vaccine Revenue Market Share by Application (2015-2020)

Figure 29. Global Varicella Live Vaccine Revenue Market Share by Application in 2019

Figure 30. North America Varicella Live Vaccine Sales Growth Rate 2015-2020 (K Units)

Figure 31. North America Varicella Live Vaccine Revenue Growth Rate 2015-2020 (US$ Million)

Figure 32. North America Varicella Live Vaccine Sales Market Share by Country in 2019

Figure 33. North America Varicella Live Vaccine Revenue Market Share by Country in 2019

Figure 34. U.S. Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 35. U.S. Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 36. Canada Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 37. Canada Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 38. North America Varicella Live Vaccine Market Share by Type in 2019

Figure 39. North America Varicella Live Vaccine Market Share by Application in 2019

Figure 40. Europe Varicella Live Vaccine Sales Growth Rate 2015-2020 (K Units)

Figure 41. Europe Varicella Live Vaccine Revenue Growth Rate 2015-2020 (US$ Million)

Figure 42. Europe Varicella Live Vaccine Sales Market Share by Country in 2019

Figure 43. Europe Varicella Live Vaccine Revenue Market Share by Country in 2019

Figure 44. Germany Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 45. Germany Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 46. France Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 47. France Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 48. U.K. Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 49. U.K. Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 50. Italy Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 51. Italy Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 52. Russia Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 53. Russia Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 54. Europe Varicella Live Vaccine Market Share by Type in 2019

Figure 55. Europe Varicella Live Vaccine Market Share by Application in 2019

Figure 56. Asia Pacific Varicella Live Vaccine Sales Growth Rate 2015-2020 (K Units)

Figure 57. Asia Pacific Varicella Live Vaccine Revenue Growth Rate 2015-2020 (US$ Million)

Figure 58. Asia Pacific Varicella Live Vaccine Sales Market Share by Region in 2019

Figure 59. Asia Pacific Varicella Live Vaccine Revenue Market Share by Region in 2019

Figure 60. China Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 61. China Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 62. Japan Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 63. Japan Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 64. South Korea Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 65. South Korea Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 66. India Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 67. India Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 68. Australia Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 69. Australia Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 70. Taiwan Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 71. Taiwan Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 72. Indonesia Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 73. Indonesia Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 74. Thailand Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 75. Thailand Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 76. Malaysia Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 77. Malaysia Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 78. Philippines Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 79. Philippines Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 80. Vietnam Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 81. Vietnam Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 82. Asia Pacific Varicella Live Vaccine Market Share by Type in 2019

Figure 83. Asia Pacific Varicella Live Vaccine Market Share by Application in 2019

Figure 84. Latin America Varicella Live Vaccine Sales Growth Rate 2015-2020 (K Units)

Figure 85. Latin America Varicella Live Vaccine Revenue Growth Rate 2015-2020 (US$ Million)

Figure 86. Latin America Varicella Live Vaccine Sales Market Share by Country in 2019

Figure 87. Latin America Varicella Live Vaccine Revenue Market Share by Country in 2019

Figure 88. Mexico Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 89. Mexico Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 90. Brazil Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 91. Brazil Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 92. Argentina Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 93. Argentina Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 94. Latin America Varicella Live Vaccine Market Share by Type in 2019

Figure 95. Latin America Varicella Live Vaccine Market Share by Application in 2019

Figure 96. Middle East and Africa Varicella Live Vaccine Sales Growth Rate 2015-2020 (K Units)

Figure 97. Middle East and Africa Varicella Live Vaccine Revenue Growth Rate 2015-2020 (US$ Million)

Figure 98. Middle East and Africa Varicella Live Vaccine Sales Market Share by Country in 2019

Figure 99. Middle East and Africa Varicella Live Vaccine Revenue Market Share by Country in 2019

Figure 100. Turkey Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 101. Turkey Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 102. Saudi Arabia Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 103. Saudi Arabia Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 104. U.A.E Varicella Live Vaccine Sales Growth Rate (2015-2020) (K Units)

Figure 105. U.A.E Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 106. Middle East and Africa Varicella Live Vaccine Market Share by Type in 2019

Figure 107. Middle East and Africa Varicella Live Vaccine Market Share by Application in 2019

Figure 108. Astellas Pharma Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 109. CSL Limited Total Revenue (US$ Million): 2019 Compared with 2018

Figure 110. Emergent BioSolutions, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 111. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018

Figure 112. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018

Figure 113. MedImmune, LLC Total Revenue (US$ Million): 2019 Compared with 2018

Figure 114. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 115. Pfizer, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 116. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018

Figure 117. Serum Institute of India Pvt. Ltd. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 118. Bavarian Nordic Total Revenue (US$ Million): 2019 Compared with 2018

Figure 119. Mitsubishi Tanabe Pharma Corporation Total Revenue (US$ Million): 2019 Compared with 2018

Figure 120. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018

Figure 121. Biological E Total Revenue (US$ Million): 2019 Compared with 2018

Figure 122. Panacea Biotec Total Revenue (US$ Million): 2019 Compared with 2018

Figure 123. North America Varicella Live Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 124. North America Varicella Live Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 125. Europe Varicella Live Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 126. Europe Varicella Live Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 127. Asia Pacific Varicella Live Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 128. Asia Pacific Varicella Live Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 129. Latin America Varicella Live Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 130. Latin America Varicella Live Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 131. Middle East and Africa Varicella Live Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 132. Middle East and Africa Varicella Live Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 133. Porter's Five Forces Analysis

Figure 134. Channels of Distribution

Figure 135. Distributors Profiles

Figure 136. Bottom-up and Top-down Approaches for This Report

Figure 137. Data Triangulation

Figure 138. Key Executives Interviewed

Astellas Pharma Inc.

CSL Limited

Emergent BioSolutions, Inc.

GlaxoSmithKline plc

Johnson & Johnson

MedImmune, LLC

Merck & Co., Inc.

Pfizer, Inc.

Sanofi Pasteur

Serum Institute of India Pvt. Ltd.

Bavarian Nordic

Mitsubishi Tanabe Pharma Corporation

Daiichi Sankyo

Biological E

Panacea Biotec

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3315

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase